ZIVO Bioscience, Inc. (ZIVO)
OTCMKTS
· Delayed Price · Currency is USD
17.51
0.00 (0.00%)
Jun 3, 2025, 8:00 PM EDT
ZIVO Bioscience Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 0.52 | 1.54 | 0.27 | 1.8 | 8.9 | 0.14 | Upgrade
|
Cash & Short-Term Investments | 0.52 | 1.54 | 0.27 | 1.8 | 8.9 | 0.14 | Upgrade
|
Cash Growth | 273.04% | 462.16% | -84.75% | -79.79% | 6357.09% | -60.17% | Upgrade
|
Receivables | - | 0 | 0 | - | - | - | Upgrade
|
Prepaid Expenses | 0.51 | 0.09 | 0.15 | 0.1 | 0.06 | 0.03 | Upgrade
|
Total Current Assets | 1.02 | 1.64 | 0.43 | 1.9 | 8.96 | 0.17 | Upgrade
|
Property, Plant & Equipment | 0.3 | - | 0.1 | 0.19 | 0.03 | 0.05 | Upgrade
|
Other Long-Term Assets | 0.01 | 0.01 | 0.03 | 0.03 | 0 | 0 | Upgrade
|
Total Assets | 1.33 | 1.64 | 0.56 | 2.12 | 8.99 | 0.22 | Upgrade
|
Accounts Payable | 0.66 | 0.74 | 1.17 | 0.49 | 0.65 | 1.56 | Upgrade
|
Accrued Expenses | 1.29 | 1.16 | 1.25 | 0.5 | 0.56 | 2.68 | Upgrade
|
Short-Term Debt | 0.44 | - | - | - | - | 0.01 | Upgrade
|
Current Portion of Long-Term Debt | 0.14 | 0.14 | 0.24 | 0.24 | 0.24 | 5.18 | Upgrade
|
Current Portion of Leases | 0.06 | - | 0.11 | 0.1 | 0.02 | 0.03 | Upgrade
|
Current Unearned Revenue | - | - | - | 0.7 | 1.48 | 1.94 | Upgrade
|
Total Current Liabilities | 2.61 | 2.04 | 2.76 | 2.03 | 2.95 | 11.39 | Upgrade
|
Long-Term Debt | 0.08 | 0.12 | - | - | - | 0.12 | Upgrade
|
Long-Term Leases | 0.25 | - | - | 0.11 | - | 0.02 | Upgrade
|
Total Liabilities | 2.95 | 2.16 | 2.76 | 2.13 | 2.95 | 11.53 | Upgrade
|
Common Stock | 0 | 0 | 0 | 0 | 0.01 | 0.01 | Upgrade
|
Additional Paid-In Capital | 139.56 | 136.45 | 121.37 | 115.79 | 113.09 | 87.75 | Upgrade
|
Retained Earnings | -141.18 | -136.97 | -123.58 | -115.8 | -107.06 | -99.06 | Upgrade
|
Shareholders' Equity | -1.62 | -0.51 | -2.21 | -0.01 | 6.04 | -11.31 | Upgrade
|
Total Liabilities & Equity | 1.33 | 1.64 | 0.56 | 2.12 | 8.99 | 0.22 | Upgrade
|
Total Debt | 0.97 | 0.25 | 0.35 | 0.45 | 0.26 | 5.36 | Upgrade
|
Net Cash (Debt) | -0.46 | 1.29 | -0.07 | 1.35 | 8.65 | -5.22 | Upgrade
|
Net Cash Growth | - | - | - | -84.34% | - | - | Upgrade
|
Net Cash Per Share | -0.13 | 0.41 | -0.04 | 0.86 | 6.80 | -6.17 | Upgrade
|
Filing Date Shares Outstanding | 3.81 | 3.76 | 2.78 | 1.57 | 1.57 | 0.87 | Upgrade
|
Total Common Shares Outstanding | 3.79 | 3.62 | 2.38 | 1.57 | 1.57 | 0.83 | Upgrade
|
Working Capital | -1.59 | -0.41 | -2.34 | -0.13 | 6.01 | -11.23 | Upgrade
|
Book Value Per Share | -0.43 | -0.14 | -0.93 | -0.01 | 3.85 | -13.68 | Upgrade
|
Tangible Book Value | -1.62 | -0.51 | -2.21 | -0.01 | 6.04 | -11.31 | Upgrade
|
Tangible Book Value Per Share | -0.43 | -0.14 | -0.93 | -0.01 | 3.85 | -13.68 | Upgrade
|
Machinery | - | - | - | - | - | 0.1 | Upgrade
|
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.